BEUDAMED
    16 results · 16ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters FDA Classification × Regulation: Us FDA × Clear all

    Light Based Imaging

    FDA classification
    FDA Class 2 ·Light Based Imaging

    Injector, Pen

    FDA classification
    FDA Class 2 ·Injector, Pen

    Crimper, Pin

    FDA classification
    FDA Class 1 ·Crimper, Pin

    Pin, Fixation, Smooth

    FDA classification
    FDA Class 2 ·Pin, Fixation, Smooth

    Pen, Marking, Surgical

    FDA classification
    FDA Class 1 ·Pen, Marking, Surgical

    Pin, Fixation, Threaded

    FDA classification
    FDA Class 2 ·Pin, Fixation, Threaded

    Driver, Surgical, Pin

    FDA classification
    FDA Class 1 ·Driver, Surgical, Pin

    Pin, Fixation, Threaded, Metallic

    FDA classification
    FDA Class 2 ·Pin, Fixation, Threaded, Metallic

    Pin, Fixation, Smooth, Metallic

    FDA classification
    FDA Class 2 ·Pin, Fixation, Smooth, Metallic

    Antiserum, Positive And Negative Febrile Antigen Control Serum

    FDA classification
    FDA Class 2 ·Antiserum, Positive And Negative Febrile Antigen Control Serum

    Filter, Conduction, Anesthetic

    FDA classification
    FDA Class 2 ·Filter, Conduction, Anesthetic

    Pin, Fixation, Resorbable, Hard Tissue

    FDA classification
    FDA Class 2 ·Pin, Fixation, Resorbable, Hard Tissue

    Pin, Retentive And Splinting, And Accessory Instruments

    FDA classification
    FDA Class 1 ·Pin, Retentive And Splinting, And Accessory Instruments

    Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief

    FDA classification
    FDA Class 2 ·Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief

    Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

    FDA classification
    FDA Class 2 ·Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

    Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers

    FDA classification
    FDA Class 2 ·Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers